Clinical significance of CD56 expression in patients with acute myeloid leukemia [4]

Leukemia and Lymphoma

Volumn 43, Issue 9, 2002, Pages 1897-1899

  Lee, Je Jung ^a   Chung, Ik Joo ^a   Yang, Duk Hwan ^a   Cho, Sang Hee ^a   Cho, Duck ^a   Ryang, Dong Wook ^a   Kim, Hyeoung Joon ^a  

^a Chonnam National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

CD56 ANTIGEN; CYTARABINE; ETOPOSIDE; GLYCOPROTEIN; IDARUBICIN; MITOXANTRONE; RETINOIC ACID;

ADOLESCENT; ADULT; AGED; ALLOGENIC BONE MARROW TRANSPLANTATION; BLOOD TRANSFUSION; CANCER MORTALITY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPHENOTYPING; LETTER; MAJOR CLINICAL STUDY; MALE; MONONUCLEAR CELL; MYELOID LEUKEMIA; NATURAL KILLER CELL; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ADOLESCENT; ADULT; AGED; ANTIGENS, CD56; FEMALE; HUMANS; IMMUNOPHENOTYPING; KARYOTYPING; LEUKEMIA, MYELOCYTIC, ACUTE; MALE; MIDDLE AGED; PROGNOSIS; TREATMENT OUTCOME;

EID: 0036336282     PISSN: 10428194     EISSN: None     Source Type: Journal    
DOI: 10.1080/1042819021000009283     Document Type: Letter

References (8)

1. "Expression of N-CAM (CD56) on acute leukemia cells: Relationship with disease characteristics and outcome"
2. "Expression of the neural cell adhesion molecule CD56 is associated with short remission duration and survival in acute myeloid leukemia with t(8;21)(q22;q22)"
3. "The clinical significance of CD34 expression in response to therapy of patients with acute myeloid leukemia: An overview of 2483 patients from 22 studies"
4. "Differences in CD14 and alpha-naphthyl acetate esterase positivity and relation to prognosis in AML"
5. "Expression of CD56/NCAM on hematopoietic malignant cells. A useful marker for acute monocytic and megakaryocytic leukemias"
6. "Nonnasal lymphoma expressing the natural killer cell marker CD56: A clinicopathologic study of 49 cases of an uncommon aggressive neoplasm"
7. "CD56 expression in acute promyelocytic leukemia: A possible indicator of poor treatment outcome?"
8. "CD56 expression is an indicator of poor clinical outcome in patients with acute promyelocytic leukemia treated with simultaneous all-trans-retinoic acid and chemotherapy"